These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 18648007)
1. The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. Chiu BC; Lan Q; Dave BJ; Blair A; Zahm SH; Weisenburger DD J Natl Cancer Inst Monogr; 2008; (39):69-73. PubMed ID: 18648007 [TBL] [Abstract][Full Text] [Related]
2. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Chiu BC; Dave BJ; Blair A; Gapstur SM; Zahm SH; Weisenburger DD Blood; 2006 Aug; 108(4):1363-9. PubMed ID: 16621961 [TBL] [Abstract][Full Text] [Related]
3. Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma. Chiu BC; Dave BJ; Ward MH; Fought AJ; Hou L; Jain S; Gapstur S; Evens AM; Zahm SH; Blair A; Weisenburger DD Cancer Causes Control; 2008 Oct; 19(8):859-67. PubMed ID: 18386141 [TBL] [Abstract][Full Text] [Related]
4. A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma (United States). Schroeder JC; Olshan AF; Baric R; Dent GA; Weinberg CR; Yount B; Cerhan JR; Lynch CF; Schuman LM; Tolbert PE; Rothman N; Cantor KP; Blair A Cancer Causes Control; 2002 Mar; 13(2):159-68. PubMed ID: 11936822 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Chang CM; Wang SS; Dave BJ; Jain S; Vasef MA; Weisenburger DD; Cozen W; Davis S; Severson RK; Lynch CF; Rothman N; Cerhan JR; Hartge P; Morton LM Int J Cancer; 2011 Aug; 129(4):938-47. PubMed ID: 20949561 [TBL] [Abstract][Full Text] [Related]
6. t(14;18) Translocations and risk of follicular lymphoma. Rabkin CS; Hirt C; Janz S; Dölken G J Natl Cancer Inst Monogr; 2008; (39):48-51. PubMed ID: 18648003 [TBL] [Abstract][Full Text] [Related]
7. A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. Chang CM; Schroeder JC; Olshan AF; Dunphy CH; Huang WY; Baric RS; Conway K; Cerhan JR; Lynch CF; Rothman N; Cantor KP; Blair A Cancer Causes Control; 2010 Jul; 21(7):1147-54. PubMed ID: 20232134 [TBL] [Abstract][Full Text] [Related]
8. Association of abnormalities of chromosome 11 with t(14;18) in diffuse non-Hodgkin's lymphoma. Lukeis R; Juneja S; Tan L; Matthews J; Cooper I; Ironside P; Garson OM Cancer Genet Cytogenet; 1994 Nov; 78(1):36-9. PubMed ID: 7987803 [TBL] [Abstract][Full Text] [Related]
15. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition? Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561 [TBL] [Abstract][Full Text] [Related]
16. Translocation t(14;18) in healthy individuals: preliminary study of its association with family history and agricultural exposure. Paltiel O; Zelenetz A; Sverdlin I; Gordon L; Ben-Yehuda D Ann Oncol; 2000; 11 Suppl 1():75-80. PubMed ID: 10707784 [TBL] [Abstract][Full Text] [Related]
17. Detection of t(14; 18)(q32;q21) in hyperdiploid cells by fluorescence in situ hybridization in a patient with Hodgkin disease. Miura I; Tamura A; Taniwaki M; Nakamura S; Nakamine H; Yoshino T; Ichinohasama R; Miura AB Cancer Genet Cytogenet; 2000 Dec; 123(2):97-101. PubMed ID: 11150598 [TBL] [Abstract][Full Text] [Related]
18. t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations. Aamot HV; Bjørnslett M; Delabie J; Heim S Br J Haematol; 2005 Sep; 130(6):845-51. PubMed ID: 16156854 [TBL] [Abstract][Full Text] [Related]
19. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BC; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami HO; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):130-44. PubMed ID: 25174034 [TBL] [Abstract][Full Text] [Related]
20. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. Ma ES Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]